ليست عنوان مقالات لاتين Cardiac Consequences of Aldosterone Excess In Human Hypertension Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac Consequences of Aldosterone Excess In Human Hypertension

2

Cardiac consequences of malnutrition—ancel keys revisited!

3

Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

4

Cardiac Contractility Modulation Electrical Signals Improve Myocardial Gene Expression in Patients With Heart Failure Original Research Article

5

Cardiac Contraction Motion Correction in Gated Myocardial Perfusion SPECT Projection Domain

6

Cardiac contusion as a primary clinical entity

7

Cardiac contusion: Ending myocardial confusion in this capricious syndrome

8

Cardiac CT Angiography of a Membranous Ventricular Septal Aneurysm Short Title: Ventricular Septal Aneurysm

9

Cardiac CT in Mixed Type Atrial Septum Defects

10

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance

11

Cardiac cytoarchitecture and myofibril attachment during development and disease

12

Cardiac cytokine expression after myocardial infarction in rats

13

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study

14

Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators

15

Cardiac death—current concepts

16

Cardiac Dedifferentiated Liposarcoma Requiring a Mitral Valve Replacement Complicated by Severe Paravalvular Leak: A Rare Case Report with Literature Review

17

Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease

18

Cardiac Deletion of the Coxsackievirus-Adenovirus Receptor Abolishes Coxsackievirus B3 Infection and Prevents Myocarditis In Vivo

19

Cardiac Denervation After Radiofrequency Ablation of Supraventricular Tachycardias

20

Cardiac denervation in amyloid polyneuropathy

21

Cardiac depression scale: Validation of a new depression scale for cardiac patients

22

Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid

23

Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix

24

Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age

25

Cardiac disease after chest irradiation for Hodgkinʹs disease: incidence in 108 patients with long follow-up

26

Cardiac disease and risk of sudden death in the young: the burden of the phenomenon

27

Cardiac disease construction on the borderland

28

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

29

Cardiac disease in pregnancy—A.I.I.M.S. experience

30

Cardiac disease, anxiety, and sexual functioning

31

Cardiac Disorder in an Iranian Child With Hepatitis A Virus

32

Cardiac disorders and mode of action of the Egyptian scorpion venom Androctonus bicolor on isolated toad’s heart

33

Cardiac drug-psychotropic drug update

34

Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer

35

Cardiac dysfunction after burns

36

Cardiac dysfunction and abnormal responses to hemodynamic stress in mice lacking s100a1 protein

37

Cardiac Dysfunction and Serum Ferritin Level as Early Prognostic Markers in Children with Sepsis: A Cross-sectional Study

38

Cardiac Dysfunction in a Child with Severe Multisystem Inflammatory Syndrome

39

Cardiac dysfunction in cirrhosis

40

Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India

41

Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis

42

Cardiac dysfunction is attenuated by ginkgolide B via reducing oxidative stress and fibrosis in diabetic rats

43

Cardiac dysfunction with Becker muscular dystrophy

44

Cardiac dysrhythmia in COVID-19 patients; occurrence and risk factors: a retrospective cohort study

45

Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia

46

Cardiac Dyssynchrony in Congestive Heart Failure and Atrial Fibrillation: Integrating Regularization and Resynchronization

47

Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy

48

Cardiac echinococcosis causing coronary artery disease

49

Cardiac Echinococcosis: Surgical Treatment and Results in 10 Cases

50

Cardiac effects of acute myelitis

51

Cardiac Effects of Antiretroviral Therapy in HIV-Negative Infants Born to HIV-Positive Mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children Cohort Study)

52

Cardiac Effects of Calcium Antagonists in Systemic Hypertension

53

Cardiac effects of exercise rehabilitation in hemodialysis patients

54

Cardiac effects of l-thyroxine administration in borderline hypothyroidism

55

Cardiac electrophysiologic effects of norepinephrine in human beings, ,

56

Cardiac Electrophysiological Consequences of Neuromuscular Incapacitating Device Discharges Original Research Article

57

Cardiac electrophysiological effects of ETA & ETB receptor stimulation in isolated working rabbit hearts

58

Cardiac Electrophysiology Studies and Ablations for Treatment of Supraventricular Arrhythmias — An Initial Experience from Karachi

59

Cardiac electrophysiology: keeping in rhythm

60

Cardiac Ellis–van Creveld syndrome

61

Cardiac encasement by metastatic myxoid liposarcoma

62

Cardiac energy metabolism alterations in angiotensin II induced hypertrophy

63

Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats

64

Cardiac Energy Metabolism Homeostasis: Role of Cytosolic Calcium

65

Cardiac energy metabolism in patients with chest pain and normal coronary angiograms

66

Cardiac Entrapment During Minimally Invasive Aortic Valve Replacement

67

Cardiac enzyme (troponin levels) elevation in cardiac myxomas: Is it real?

68

Cardiac enzyme elevations after cardiac surgery: The cardiologistʹs perspective

69

Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality

70

Cardiac enzyme in emergency medicine

71

Cardiac enzymes and autotransfusion of shed mediastinal blood after myocardial revascularization

72

Cardiac epithelioid hemangioendothelioma with 8-year follow-up

73

CARDIAC EVALUATION OF PATIENTS WITH ISCHEMIC STROKE

74

Cardiac Event Rates After Acute Myocardial Infarction in Patients Treated With Verapamil and Trandolapril Versus Trandolapril Alone

75

Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: Importance of resting wall motion abnormalities Original Research Article

76

Cardiac Excrescences of Unusual Origin

77

Cardiac Expression and Subcellular Localization of the p38 Mitogen-activated Protein Kinase Member, Stress-activated Protein Kinase-3 (SAPK3)

78

Cardiac expression of glucocorticoid receptor α in mice

79

Cardiac expression of ID1 and ID3 is stimulated by chronic ischemia

80

Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients With Acute Myocardial Infarction Original Research Article

81

Cardiac Expression of Sarcolipin Calpain After Immobilization Stress in Young Old Female Rats, Role of Alpha Beta Adrenoceptor Blockers

82

Cardiac extrinsic neuropathy: Lesions of the mediastinal paraganglia in chronic chagasic cardiomyopathy

83

Cardiac factors affecting the success of vardenafil in erectile dysfunction

84

Cardiac fatigue and oxygen kinetics after prolonged exercise

85

Cardiac Fibroblasts: Form and Function

86

Cardiac Fibroelastoma versus Thrombus: Echocardiographic Evidence Can Be Misleading

87

Cardiac Fibroma

88

Cardiac Fibroma in a Neonate Presenting With Dyspnea and Tachycardia: A Very Rare Case

89

Cardiac fibroma in an infant: single ventricle palliation as a bridge to heart transplantation

90

Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude

91

Cardiac Fibrosis in Human Transplanted Hearts Is Mainly Driven by Cells of Intracardiac Origin

92

Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II

93

Cardiac Findings After Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

94

Cardiac Findings in Congenital Nephrotic Syndrome

95

Cardiac flow component analysis

96

Cardiac function and heart failure

97

Cardiac Function and Heart Failure Review Article

98

Cardiac Function and Heart Failure Review Article

99

Cardiac Function and Position More Than 5 Years After Pneumonectomy

100

Cardiac function at rest in hypothyroidism evaluated by equilibrium radionuclide angiography

101

Cardiac Function Before and After Surgery for Pectus Excavatum

102

Cardiac Function Before and After Surgery for Pectus Excavatum

103

Cardiac function during mild hypothermia in human-sized pigs: Increased inotropy at the cost of diastolic dysfunction

104

Cardiac function estimation from MRI using a heart model and data assimilation: Advances and difficulties

105

Cardiac Function in Brain Death, Usage of Advanced Hemodynamic Monitoring

106

Cardiac function in smokers and nonsmokers: The CARDI study

107

Cardiac Function Modeling in Patients With Acute Myocardial Infarction Based on Type D Personality Considering the Mediating Role of Health-Promoting Lifestyle

108

Cardiac glycosides could protect brain cells from stroke

109

Cardiac hemangioendothelioma

110

Cardiac Hemangioma

111

Cardiac Hemangioma: A Benign Tumor with Different Morphological Appearances

112

Cardiac hemochromatosis

113

Cardiac Hemodynamic and Coronary Angiographic Characteristics of Patients Being Evaluated for Liver Transplantation

114

Cardiac Hemodynamics in Men Versus Women During Acute ST-Segment Elevation Myocardial Infarction

115

Cardiac Hemosiderosis in Transfusion DependentThalassemia: A Mini-Review

116

Cardiac Hepatopathy Versus End-Stage Liver Disease: Two Different Entities

117

Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome

118

Cardiac hormone: predictive of prognosis

119

Cardiac hydatid cyst located in the interventricular septum

120

Cardiac Hydatid Cyst without Liver Involvement: A Case Re-port

121

Cardiac Hydatid Cyst: A Case Report

122

Cardiac Hydatid Cyst: A Case Report

123

Cardiac hydatid cyst: A rare presentation of echinococcal infection

124

Cardiac Hydatid Cyst: An Unusual Cause of Chest Pain

125

Cardiac hydatid cysts

126

Cardiac hydatid cysts with intracavitary expansion

127

Cardiac hydatid cysts: Reply

128

Cardiac hydatidosis : A rare infection of the heart with hydatid cyst of Echinococcus granulosus can produced anaemia

129

Cardiac Hypertrophy Alters Expression of Na+,K+-ATPase Subunit Isoforms at mRNA and Protein Levels in Rat Myocardium

130

Cardiac Hypertrophy Due to Hydrocortisone Treatment in a Preterm Infant: A Case Report

131

Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1

132

Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings

133

Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness

134

Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein

135

Cardiac hypertrophy in the prague hypertensive rat (PHR) is associated with enhanced JNK2 but not ERK tissue activity

136

Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart

137

Cardiac imaging

138

Cardiac imaging

139

Cardiac Imaging in FIP1L1-PDGFRA

140

Cardiac Imaging in Patients With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure

141

Cardiac imaging in the evaluation of mitral annulus caseous calcification

142

Cardiac Imaging Integration in 2009 and Beyond

143

Cardiac Imaging Integration in 2009 and Beyond: Cardiovascular magnetic resonance

144

Cardiac Imaging Secrets: Neil J. Weissman and Gabriel A. Adelmann, Eds., Philadelphia, PA: Hanley and Belfus, 2003, 350 pages, 100 illustrations, US$36.95.

145

Cardiac imaging using optison

146

Cardiac imaging—the requisites, 2nd edition. Stephen Wilmot Miller (Ed). Philadelphia, PA: Mosby, imprint of Elsevier Science, 2004, 464 pages, 894 illustrations (US$99.00).

147

Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients

148

Cardiac implications of Lyme disease, diagnosis and therapeutic approach

149

Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: Relation to arising time

150

Cardiac index quantification by Doppler ultrasound in patients without left ventricular outflow tract abnormalities

151

Cardiac infections: focus on molecular diagnosis

152

Cardiac Infertility in Persian Medicine: Avicenna’s View

153

Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats

154

Cardiac inhibitory response to alpha stimulation is blunted in young patients with essential hypertension.

155

Cardiac Injuries: A Review of Multidetector Computed Tomography Findings

156

Cardiac injury by a nail gun

157

Cardiac Injury by Activated Leukocytes: Effect of Cyclooxygenase and Lipoxygenase Inhibition Evaluated by Electron Microscopical Morphometry

158

Cardiac instrument development in a low-literacy population: The revised Chest Discomfort Diary

159

Cardiac Integrins: The Ties That Bind

160

Cardiac Intensivism: A View From a Fellow-in-Training

161

Cardiac intracavitary metastasis of a malignant solitary fibrous tumor: case report and review of the literature on sarcomas with left intracavitary extension

162

Cardiac involvement according to echocardiographic findings in severe coronavirus disease 2019

163

Cardiac Involvement and Echocardiographic Characteristics in Rheumatoid Arthritis

164

Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature

165

Cardiac involvement in a case of acute lymphoblastic leukemia

166

Cardiac Involvement in a Fetus With Vein of Galen Aneurysmal Malformation, Diagnosis, and Treatment: A Case Report

167

Cardiac Involvement in a Patient with Eosinophilia and Inversion of Chromosome 16(p13q22): A Case of Chronic Eosinophilic Leukemia or AML-M4EO?

168

Cardiac Involvement in Adults With m.3243A>G MELAS Gene Mutation

169

Cardiac involvement in childhood polyarteritis nodosa

170

Cardiac involvement in Dengue Haemorrhagic Fever

171

Cardiac Involvement in Lysosomal Diseases

172

Cardiac Involvement in Mild Cystic Fibrosis Lung Involvement Assessed by Tissue‐Doppler Echocardiography

173

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

174

Cardiac Involvement in Non-Hodgkin Lymphoma, an Incidental Large Atrial Mass: A Case Report

175

Cardiac Involvement in Systemic Lupus Erythematosus: Echocardiographic Evaluation

176

Cardiac involvement in systemic rheumatic diseases: An update

177

Cardiac Involvement in the Churg-Strauss Syndrome

178

Cardiac Involvement in Von Hippel-Lindau Disease

179

Cardiac involvement in Wegener granulomatosis diagnosed at autopsy

180

Cardiac involvement is a constant finding in acute Chagasʹ disease: a clinical, parasitological and histopathological study

181

Cardiac involvement over 10 years in myotonic and Becker muscular dystrophy and mitochondrial disorder

182

Cardiac Involvement with Diffuse Large B Cell Lymphoma

183

Cardiac Involvements in Patients with Celiac Disease by Doppler Tissue Echocardiography Compared to Conventional Echocardiography

184

Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results From a Comparative Study With Si

185

Cardiac ion channel expression and regulation: the role of innervation

186

Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity

187

Cardiac ion channels and channelopathies

188

Cardiac ischemia/reperfusion, aging, and redox-dependent alterations in mitochondrial function

189

Cardiac ischemic preconditioning improves lung preservation in valve replacement operations

190

Cardiac isoform of alpha-2 macroglobulin—A new biomarker for myocardial infarcted diabetic patients

191

Cardiac issues related to trastuzumab

192

Cardiac KATP channels in health and disease

193

Cardiac Lipoma: An Uncharacteristically Large Intra-Atrial Mass Causing Symptoms

194

Cardiac Luxation to Facilitate Off-Pump Bilateral Lung Transplantation

195

Cardiac Lymphoma Following Mitral Valve Replacement

196

Cardiac Magnetic Resonance and the Need for Routine Cardiac Catheterization in Single Ventricle Patients Prior to Fontan: A Comparison of 3 Groups: Pre-Fontan CMR Versus Cath Evaluation

197

Cardiac Magnetic Resonance Detection of Myocardial Scarring in Hypertrophic Cardiomyopathy: Correlation With Histopathology and Prevalence of Ventricular Tachycardia

198

Cardiac magnetic resonance documentation of a double atrial septal defect before and after percutaneous closure with an Amplatzer septal occluder

199

Cardiac Magnetic Resonance Evaluation of the Impact of Interventricular and Intraventricular Dyssynchrony on Cardiac Ventricular Systolic and Diastolic Function in Patients With Isolated Left Bundle Branch Block

200

Cardiac Magnetic Resonance Findings in Congenitally Absent Pericardium

201

Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease

202

Cardiac Magnetic Resonance for Risk Stratification of Patients With Frequent Premature Ventricular Contractions

203

Cardiac magnetic resonance imaging and core cardiology training II (COCATS-2): Can we get there from here?

204

Cardiac Magnetic Resonance Imaging and Coronary Computed Tomography Angiography in the Diagnosis of Anomalous Coronary Artery

205

Cardiac Magnetic Resonance Imaging and the Assessment of Ebstein Anomaly in Adults

206

Cardiac Magnetic Resonance Imaging and the WATCHMAN Device

207

Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiography in Patients With Transcatheter Closure of Patent Foramen Ovale Original Research Article

208

Cardiac Magnetic Resonance Imaging Correlates of Exercise Capacity in Patients With Surgically Repaired Tetralogy of Fallot

209

Cardiac Magnetic Resonance Imaging Findings and the Risk of Cardiovascular Events in Patients With Recent Myocardial Infarction or Suspected or Known Coronary Artery Disease: A Systematic Review of Prognostic Studies

210

Cardiac Magnetic Resonance Imaging Findings in a Patient with Ebstein’s Anomaly and Left Ventricular Dysfunction

211

Cardiac magnetic resonance imaging findings in a patient with noncompaction of ventricular myocardium

212

Cardiac Magnetic Resonance Imaging for Accurate Diagnosis of Aortic Arch Anomalies in Patients with 22q11.2 Deletion

213

Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Sarcoidosis: A Meta-Analysis

214

Cardiac Magnetic Resonance Imaging Identification of Myocardial Fibrosis: The Need for Standardization and Therapies

215

Cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy: correlation to the QRS dispersion

216

Cardiac magnetic resonance imaging in small animal models of human heart failure

217

Cardiac magnetic resonance imaging in the diagnosis of myocarditis mimicking myocardial infarction

218

Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer

219

Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

220

Cardiac magnetic resonance imaging of systemic amyloidosis patients with normal left ventricular ejection fraction: An initial study

221

Cardiac Magnetic Resonance Imaging Signal Characteristics of Cardiac Tumors in Children

222

Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T Original Research Article

223

Cardiac magnetic resonance imaging training

224

Cardiac magnetic resonance imaging using radial k-space sampling and self-calibrated partial parallel reconstruction

225

Cardiac magnetic resonance imaging: A teaching atlas with emphasizing current clinical indications

226

Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease

227

Cardiac magnetic resonance in outpatients in Germany—indications, complications and protocol suggestions from a high-volume center

228

Cardiac Magnetic Resonance Measurements of Area at Risk and Infarct Size in Ischemic Syndromes

229

Cardiac Magnetic Resonance Predicts Outcome in Patients With Premature Ventricular Complexes of Left Bundle Branch Block Morphology

230

Cardiac magnetic resonance training: How we can get there from here

231

Cardiac Magnetic Resonance With Edema Imaging Identifies Myocardium at Risk and Predicts Worse Outcome in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

232

Cardiac Magnetic Resonance-Directed Intervention in Non–ST-Segment Elevation Acute Coronary Syndrome

233

Cardiac Malformations in Fetuses of Gestational and Pre Gestational Diabetic Mothers

234

Cardiac malignant lymphoma with atrial arrhythmias

235

Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center

236

Cardiac Manifestation of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

237

Cardiac manifestations in antiphospholipid syndrome

238

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population

239

Cardiac Manifestations in Iranian Patients with Behçet’s Disease

240

Cardiac manifestations of Anderson–Fabry disease in heterozygous females

241

Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection

242

Cardiac marker testing: Where should we focus?

243

Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction

244

Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome

245

Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing?

246

Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic Syndrome: The Strong Heart Study

247

Cardiac Markers: Centralized or Decentralized Testing?

248

Cardiac mass of the right atrium: an incidental finding

249

Cardiac mass-to-maximum power output: A novel index to assess left ventricular efficiency during exercise stress echocardiography

250

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog

251

Cardiac Mast Cells: Implications for Heart Failure

252

Cardiac material markers from tagged MR images

253

Cardiac matrix metalloproteinase activation in patients undergoing coronary artery bypass grafting

254

Cardiac Medical Therapy Following Coronary Artery Bypass Graft Surgery

255

Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials Review Article

256

Cardiac Medical Therapy Post-Coronary Bypass Grafting

257

258

Cardiac Memory versus Likelihood of Ischemic Heart Disease in Hypertensive Patients with Ventricular Repolarization Abnormalities after Repetitive Uniform Ventricular Extrasystoles

259

Cardiac metabolism and function in type 2 diabetic (db/db) mice — Effect of PPARα agonist treatment

260

Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis

261

Cardiac Metal Contents After Infusions of Manganese An Experimental Evaluation in the Isolated Rat Heart

262

Cardiac Metastases of Malignant Melanoma

263

Cardiac metastasis after squamous cell carcinoma of the oral cavity: Case report

264

Cardiac Metastasis from a Renal Cell Carcinoma without Contiguous Vena Caval Involvement

265

Cardiac metastasis from a urothelial cell carcinoma: a commented case report

266

Cardiac metastasis mimicking acute STelevation myocardial infarction

267

Cardiac metastasis of tongue cancer may cause sudden death

268

Cardiac Metastatic Melanoma Investigated by Magnetic Resonance Imaging

269

Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism

270

Cardiac Misconceptions and Patients Point of View about Explanation of Medical Diagnosis and the Therapeutic Regimen

271

Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related

272

Cardiac modulation of startle: Effects on eye blink and higher cognitive processing

273

Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device

274

Cardiac monitoring after phenytoin overdose

275

Cardiac Monitoring Of Children With Household Electrical Injuries, ,

276

Cardiac morphogenetic defects and conduction abnormalities in mice homozygously deficient for connexin40 and heterozygously deficient for connexin45

277

Cardiac Morphology and Function in Senescent Rats: Gender-Related Differences

278

Cardiac Morphology and Left Ventricular Function in Normotensive Morbidly Obese Patients With and Without Congestive Heart Failure, and Effect of Weight Loss

279

Cardiac motion recovery using an incompressible B-solid model

280

Cardiac MRI in a Patient with Amyloidosis

281

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

282

Cardiac MRI in a Patient with Coincident Left Ventricular Non-Compaction and Hypertrophic Cardiomyopathy

283

Cardiac MRI in a Patient with Myocarditis

284

Cardiac MRI of ischemic heart disease at 3 T: potential and challenges

285

Cardiac multidetector-row computed tomography in patients with unstable angina

286

Cardiac muscle tissue engineering

287

Cardiac myocyte cytokinesis: The contractile ring is the thing

288

Cardiac myocyte nuclear size and ploidy status decrease after mechanical support

289

Cardiac myocyte proliferation requires activation of protein kinase C-epsilon

290

Cardiac myocytes derived from Nkx2.5-GFP knock-in murine embryonic stem cell: Electrophysiological differentiation and coupling with native cardiac myocytes

291

Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA

292

Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR

293

Cardiac Myofilament Protein Function is Altered During Sepsis

294

Cardiac myofilaments: mechanics and regulation

295

Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay

296

Cardiac myosin heavy chain isoenzymes and self ventricular defibrillation

297

Cardiac myosin phosphatase

298

Cardiac Myosin-Binding Protein C (MyBP-C): Identification of Protein Kinase A and Protein Kinase C Phosphorylation Sites

299

Cardiac Myxoma Removal and Coronary Artery Bypass Grafting in a MiddleAged Woman: A Case Report

300

Cardiac Myxoma with Glandular Component

301

Cardiac Myxoma, a Rare but Most Common Encountered Cardiac Tumor: A Single Center Experience

302

Cardiac Myxoma: 40 Years’ Experience in 63 Patients

303

Cardiac myxoma: a cytogenetic study of two cases

304

Cardiac myxoma: clinical experiences with twenty-five patients in Korea

305

Cardiac myxomas: Clinical and echocardiographic profile

306

Cardiac myxosarcoma: A case report

307

Cardiac NA,K-ATPase during hypertension: Regulatory role of nitric oxide

308

Cardiac Na/Ca Exchange Function in Rabbit, Mouse and Man: Whatʹs the Difference?

309

Cardiac Na+–H+Exchanger During Postnatal Development in the Rat: Changes in mRNA Expression and Sarcolemmal Activity

310

Cardiac Natriuretic Peptides: Gaining Further Insights Into Structure–Function Relationships

311

Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats

312

Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy

313

Cardiac nitric oxide synthases are elevated in dietary copper deficiency

314

Cardiac nociceptors innervated by vagal afferents in rats

315

Cardiac Noradrenaline Release Accelerates Adenosine Formation in the Ischemic Rat Heart: Role of Neuronal Noradrenaline Carrier and Adrenergic Receptors

316

Cardiac nuclear medicine studies

317

Cardiac observations late after operative transmyocardial laser “revascularization”

318

Cardiac operation for a patient with autoimmune hemolytic anemia with warm-reactive antibodies

319

Cardiac operations during pregnancy: review of factors influencing fetal outcome

320

Cardiac Operations in Children With Marfan’s Syndrome: Indications and Results

321

Cardiac operations in octogenarians: perioperative risk factors for death and impaired autonomy

322

Cardiac Operations in Patients 80 Years Old and Older

323

Cardiac Operations in Patients 90 Years of Age and Older

324

Cardiac operations in patients aged 70 years and over: Mortality, length of stay, and hospital charge

325

Cardiac Operations in Patients With Cirrhosis

326

Cardiac Operations in Solid-Organ Transplant Recipients

327

Cardiac operations in the elderly: who is at risk?

328

Cardiac Origins of the Postural Orthostatic Tachycardia Syndrome

329

Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities: Zaroff JG, Rordorf GA, Newell JB, et al Neurosurgery 44:34–40 January 1999

330

Cardiac Outcomes in Coronary Patients With Submaximum Dobutamine Stress Echocardiography

331

Cardiac Outcomes in Young Adult Survivors of the Arterial Switch Operation for Transposition of the Great Arteries

332

Cardiac Outcomes With Submaximal Normal Stress Echocardiography: A Meta-Analysis

333

Cardiac Output Augmentation During Hypoxemia Improves Cerebral Metabolism After Hypothermic Cardiopulmonary Bypass

334

Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing

335

Cardiac output response to dynamic exercise after atrial switch repair for transposition of the great arteries

336

Cardiac Output Responses During Exercise in Volume-Expanded Heart Transplant Recipients

337

Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: Role of insulin signaling and ER stress

338

Cardiac overexpression of the α1A-adrenergic receptor limits post-infarct ventricular remodeling and dysfunction, and improves survival

339

Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase

340

Cardiac oxygenation by extracorporeal membrane oxygenation in exteriorized fetal lambs, , ,

341

Cardiac pacemaker cell failure with preserved If, ICaL, and IKr: A lesson about pacemaker function learned from ischemia-induced bradycardia

342

Cardiac pacemaker dysfunction in children after thoracic drainage catheter manipulation

343

Cardiac Pacemaker Infection: Surgical Management With and Without Extracorporeal Circulation

344

Cardiac pacemaker lead extraction using conventional techniques:a single centre experience

345

Cardiac pacemaker: In vitro assessment at 1.5 T

346

Cardiac pacemakers: Evaluation and management of malfunctions

347

Cardiac pacemaking: If vs. Ca2+, is it really that simple?

348

349

350

Cardiac Pacing and Psychologic Disorders

351

Cardiac pacing in balloon aortic valvuloplasty

352

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation

353

Cardiac pacing: atrial fibrillation may go unrecognised

354

Cardiac pacing: the state of the art

355

Cardiac papillary fibroelastoma

356

Cardiac papillary fibroelastoma

357

Cardiac Papillary Fibroelastoma

358

Cardiac papillary fibroelastoma as a reason of transient ischemic attack for a young patient

359

Cardiac papillary fibroelastoma in left ventricular apex

360

Cardiac papillary fibroelastoma manifested as a left ventricular cystic mass

361

Cardiac papillary fibroelastoma on the pulmonary valve: a rare cardiac tumor

362

Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases

363

Cardiac papillary fibroelastomas: Rationale for excision

364

Cardiac Paraganglioma Presenting With Acute Myocardial Infarction and Stroke

365

Cardiac Paraganglioma, Recent Advances in Clinicopathologic Features

366

Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes

367

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

368

Cardiac Parasympathetic Reactivation in Elite Soccer Players During Different Types of Traditional High-Intensity Training Exercise Modes and Specific Tests: Interests and Limits

369

Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women

370

Cardiac pathological changes of Atlantic salmon (Salmo salar L.) affected with heart and skeletal muscle inflammation (HSMI)

371

Cardiac patients’ beliefs about their illness and treatment: A sequential exploratory mixed methods design

372

Cardiac patients’ perception about psychological risk factors on chest pain intensity and discomfort

373

Cardiac pentastomiasis and tuberculosis: The worm-eaten heart

374

Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice

375

Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder Original Research Article

376

Cardiac performance early after cardioversion from atrial fibrillation, , , , ,

377

CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

378

Cardiac performance is reduced following high-fat diet

379

Cardiac Performance Measure Compliance in Outpatients: The American College of Cardiology and National Cardiovascular Data Registryʹs PINNACLE (Practice Innovation And Clinical Excellence) Program

380

Cardiac phenotypes in relaxin knockout mice: Importance of the gender

381

Cardiac pheochromocytoma

382

Cardiac pheochromocytoma: resection after diagnosis by 111-indium octreotide scan

383

Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis

384

Cardiac Physical Diagnosis in the Digital Age: An Important but Increasingly Neglected Skill (from Stethoscopes to Microchips)

385

Cardiac plasmacytoma

386

Cardiac Positron Emission Tomography

387

Cardiac positron emission tomography and the role of adenosine pharmacologic stress

388

Cardiac Positron Emission Tomography as a Prognostic Indicator of Cardiac Sarcoidosis

389

Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

390

Cardiac positron emission tomography imaging with [11c]hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure

391

Cardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy

392

Cardiac potassium channel dysfunction in sudden infant death syndrome

393

Cardiac potassium currents and channels: Part II: Implications for clinical practice and therapy

394

Cardiac potassium currents and channels-Part I: Basic science aspects

395

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry Original Research Article

396

Cardiac Power Output during Dobutamine Stress Test in Horses

397

Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease

398

Cardiac problems related to burns and/or burn treatment

399

Cardiac procedure use following acute myocardial infarction among American Indians

400

Cardiac Procedures in Lung Transplant Recipients Do Not Increase Mortality in Selected Patients

401

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

402

Cardiac progenitor cells application in cardiovascular disease

403

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

404

Cardiac protection: Evolving role of angiotensin receptor blockers

405

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

406

Cardiac pulsations in patients with isolated right ventricular infarction

407

Cardiac Regeneration Review Article

408

Cardiac Rehab: Bridging the Transition from Hospital to Home

409

Cardiac rehabilitation

410

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

411

Cardiac rehabilitation and depression

412

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

413

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

414

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

415

Cardiac Rehabilitation and Survival in Older Coronary Patients

416

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

417

Cardiac Rehabilitation Following Myocardial Infarction

418

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

419

Cardiac rehabilitation I: review of psychosocial factors

420

Cardiac rehabilitation II: referral and participation

421

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

422

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

423

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

424

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

425

Cardiac rehabilitation in the elderly

426

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

427

Cardiac rehabilitation services in England and Wales: a national survey

428

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

429

Cardiac Rehabilitation, Exercise Training, and Anxiety

430

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

431

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

432

Cardiac rehabilitation: A review of current developments

433

Cardiac rehabilitation: How can it be improved?

434

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

435

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

436

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

437

Cardiac remodeling after long term norepinephrine treatment in rats

438

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

439

Cardiac remodeling and failure: From molecules to man (Part I)

440

Cardiac remodeling and failure: From molecules to man (Part II)

441

Cardiac remodeling and failure: From molecules to man (Part III)

442

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

443

Cardiac remodeling in coronary artery disease

444

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

445

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

446

Cardiac remodeling: is 8 the heart’s lucky number?

447

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

448

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

449

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

450

Cardiac reoperation in the intensive care unit

451

Cardiac reoperations in octogenarians: analysis of outcomes

452

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

453

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

454

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

455

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

456

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

457

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

458

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

459

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

460

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

461

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

462

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

463

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

464

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

465

Cardiac resynchronisation – a new standard in heart failure therapy

466

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

467

Cardiac Resynchronisation Therapy in Heart Failure

468

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

469

Cardiac resynchronization by pacing: an electrical treatment of heart failure

470

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

471

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

472

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

473

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

474

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

475

Cardiac Resynchronization Therapy

476

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

477

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

478

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

479

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

480

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

481

Cardiac Resynchronization Therapy for the Failing Fontan Patient

482

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

483

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

484

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

485

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

486

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

487

Cardiac resynchronization therapy in congenital heart disease

488

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

489

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

490

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

491

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

492

Cardiac resynchronization therapy in patients with narrow QRS

493

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

494

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

495

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

496

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

497

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

498

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

499

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

500

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

501

Cardiac resynchronization therapy upregulates cardiac autonomic control

502

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

503

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

504

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

505

Cardiac resynchronization therapy: A regulatory perspective

506

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

507

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

508

Cardiac resynchronization therapy: caveat medicus! Review Article

509

Cardiac Resynchronization Therapy: Location Matters

510

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

511

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

512

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

513

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

514

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

515

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

516

Cardiac retransplantation in children

517

Cardiac rhabdomyoma

518

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

519

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

520

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

521

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

522

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

523

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

524

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

525

Cardiac risk factors

526

Cardiac risk factors

527

Cardiac risk for vascular surgery

528

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

529

Cardiac risk in pregnant women with rheumatic mitral stenosis

530

Cardiac risk management in severe mental illness

531

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

532

Cardiac risk stratification

533

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

534

Cardiac risk: Theme con variations

535

Cardiac rupture – experience-based cardiology

536

Cardiac Rupture After Catheter Ablation Procedure

537

Cardiac rupture and tamponade during ventriculography

538

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

539

Cardiac rupture complicating myocardial infarction

540

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

541

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

542

Cardiac Rupture During Vacuum-Assisted Closure Therapy

543

Cardiac rupture or pericardial effusion?

544

Cardiac Sarcoidosis

545

Cardiac Sarcoidosis

546

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

547

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

548

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

549

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

550

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

551

Cardiac Sca-1+ and side population cells in cardiac regeneration

552

Cardiac screening proposed for HIV-1-infected children

553

Cardiac sensitization: methodology and interpretation in risk assessment

554

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

555

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

556

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

557

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

558

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

559

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

560

Cardiac stabilizer for minimally invasive direct coronary artery bypass

561

Cardiac state diagnosis using adaptive neuro-fuzzy technique

562

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

563

Cardiac Steatosis and Myocardial Dysfunction

564

Cardiac Stem Cell Transplantation

565

Cardiac stem cells and myocardial disease

566

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

567

Cardiac stents: the next generation

568

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

569

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

570

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

571

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

572

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

573

Cardiac structure and function Review Article

574

Cardiac structure and function after short-term ethanol consumption in rats

575

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

576

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

577

Cardiac Structure and Function in Persons 85 Years of Age

578

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

579

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

580

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

581

Cardiac surgeons in England face publication of outcomes data

582

Cardiac surgery

583

Cardiac surgery and cold-reactive proteins

584

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

585

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

586

Cardiac surgery for octogenarians: is it an informed decision?

587

Cardiac surgery in a fixed-reimbursement environment

588

Cardiac surgery in African Americans

589

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

590

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

591

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

592

Cardiac surgery in octogenarians with poor lung function

593

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

594

Cardiac surgery in octogenarians: have we gone too far or not far enough?

595

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

596

Cardiac surgery in patients infected with the human immunodeficiency virus

597

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

598

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

599

Cardiac surgery in patients with end-stage renal disease: 10-year experience

600

Cardiac Surgery in Patients With Liver Cirrhosis

601

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

602

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

603

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

604

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

605

Cardiac surgery report cards: comprehensive review and statistical critique

606

Cardiac surgery report cards: making the grade

607

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

608

Cardiac Surgery Risk Models: A Position Article

609

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

610

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

611

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

612

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

613

Cardiac surgical implications of calcium dyshomeostasis in the heart

614

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

615

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

616

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

617

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

618

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

619

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

620

Cardiac sympathetic innervation and control of potassium channel function

621

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

622

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

623

Cardiac syndrome X versus metabolic syndrome X

624

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

625

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

626

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

627

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

628

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

629

Cardiac tamponade as a life-threatening complication in antireflux surgery

630

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

631

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

632

Cardiac tamponade as manifestation of advanced thymic carcinoma

633

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

634

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

635

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

636

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

637

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

638

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

639

Cardiac tamponade due to pneumopericardium

640

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

641

Cardiac tamponade during thoracic endovascular aortic repair

642

Cardiac tamponade following pacemaker implantation

643

Cardiac tamponade from central venous catheters

644

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

645

Cardiac tamponade in a neglected case of thyroid agenesis

646

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

647

Cardiac tamponade in acquired immunodeficiency syndrome

648

Cardiac tamponade in acute rheumatic fever

649

Cardiac tamponade in Hashimotoʹs disease

650

Cardiac tamponade in hereditary hemorrhagic telangiectasia

651

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

652

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

653

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

654

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

655

Cardiac tamponade without pericardial effusion after blunt chest trauma

656

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

657

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

658

Cardiac teratogenicity of trichloroethylene metabolites

659

Cardiac thromboemboli complicating a stab wound to the heart

660

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

661

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

662

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

663

Cardiac toxicity of sunitinib

664

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

665

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

666

Cardiac Transplant Following Failed Fontan or Glenn Procedures

667

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

668

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

669

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

670

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

671

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

672

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

673

Cardiac transplantation for the cardiologist not trained in transplantation

674

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

675

Cardiac transplantation in a patient with protein S deficiency

676

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

677

Cardiac Transplantation in Adults With Small Hearts

678

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

679

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

680

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

681

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

682

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

683

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

684

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

685

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

686

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

687

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

688

Cardiac troponin I

689

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

690

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

691

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

692

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

693

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

694

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

695

Cardiac troponin I as a marker for AMI

696

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

697

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

698

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

699

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

700

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

701

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

702

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

703

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

704

Cardiac troponin i in acute pericarditis

705

Cardiac troponin I in aortic valve disease

706

Cardiac troponin I in neonates undergoing the arterial switch operation

707

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

708

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

709

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

710

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

711

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

712

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

713

Cardiac troponin I proves less accurate in low-risk cardiac patients

714

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

715

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

716

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

717

Cardiac troponin I release in heart transplantation

718

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

719

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

720

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

721

Cardiac Troponin Increases Among Runners in the Boston Marathon

722

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

723

Cardiac troponin release in response to transient ST segment depression

724

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

725

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

726

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

727

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

728

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

729

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

730

Cardiac troponin T concentration after coronary balloon angioplasty

731

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

732

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

733

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

734

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

735

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

736

Cardiac troponin T levels in umbilical cord blood,

737

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

738

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

739

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

740

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

741

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

742

Cardiac troponin-I content of skeletal muscle in patients with renal failure

743

Cardiac troponins after a downhill marathon

744

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

745

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

746

Cardiac troponins in congestive heart failure, ,

747

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

748

Cardiac troponins in renal insufficiency: Review and clinical implications

749

Cardiac Troponins in Young Marathon Runners

750

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

751

Cardiac troponins: IT upgrade for the heart

752

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

753

Cardiac tuberculosis presenting as small intestinal gangrene

754

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

755

Cardiac tumor due to Erdheim-Chester disease

756

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

757

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

758

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

759

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

760

Cardiac Uses of Phosphodiesterase-5 Inhibitors

761

Cardiac vagal activity: a target for intervention in heart disease

762

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

763

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

764

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

765

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

766

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

767

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

768

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

769

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

770

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

771

Cardiac valve replacement in human immunodeficiency virus–infected patients

772

Cardiac valve replacement in patients on dialysis

773

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

774

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

775

Cardiac Valvular Calcification in Hemodialysis Patients

776

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

777

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

778

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

779

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

780

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

781

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

782

Cardiac Whipple’s disease without digestive symptoms

783

Cardiac Xenotransplantation

784

Cardiac xenotransplantation: clinical experience and future direction

785

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

786

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

787

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

788

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

789

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

790

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

791

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

792

Cardiac-specific Gene Expression: a HANDful of Factors

793

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

794

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

795

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

796

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

797

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

798

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

799

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

800

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

801

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

802

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

803

Cardinal B-spline dictionaries on a compact interval

804

Cardinal characteristics and projective wellorders

805

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

806

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

807

Cardinal characteristics for Menger-bounded subgroups

808

Cardinal directions between spatial objects: the pairwise-consistency problem

809

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

810

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

811

Cardinal functions of Pixley–Roy hyperspaces

812

Cardinal Interpolating Multiresolutions Original Research Article

813

Cardinal interpolation with polysplines on annuli Original Research Article

814

Cardinal invariants about shrinkability of unbounded sets

815

Cardinal invariants above the continuum Original Research Article

816

Cardinal invariants and -factorizability in paratopological groups

817

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

818

Cardinal invariants in locally -minimal paratopological groups

819

Cardinal invariants of monotonically normal spaces

820

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

821

Cardinal invariants related to permutation groups

822

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

823

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

824

Cardinal sequences

825

Cardinal sequences of LCS spaces under GCH

826

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

827

Cardinal temperatures for germination of Kochia scoparia (L.)

828

Cardinal transfer properties in extender models

829

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

830

Cardinalities in depth: a formal approach to partial validation of conceptual schema

831

Cardinalities of ccc-spaces with regular -diagonals

832

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

833

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

834

Cardinality and the borda score

835

Cardinality Approach to Fuzzy Number Arithmetic

836

Cardinality bounds for subdirectly irreducible algebras Original Research Article

837

Cardinality concepts for type-two fuzzy sets

838

Cardinality constrained Boolean quadratic polytope Original Research Article

839

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

840

Cardinality, quantifiers, and the aggregation of fuzzy criteria

841

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

842

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

843

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

844

Cardioactive steroid poisoning from an herbal cleansing preparation

845

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

846

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

847

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

848

Cardiocerebral Resuscitation for Cardiac Arrest

849

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

850

Cardiocerebral Resuscitation: A Broader Perspective

851

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

852

Cardio-cerebrovascular complications in elderly with diabetes

853

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

854

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

855

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

856

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

857

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

858

Cardioembolic Stroke

859

Cardioembolic stroke: an update

860

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

861

Cardio-facio-cutaneous syndrome and moyamoya syndrome

862

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

863

Cardiogenic and Aortogenic Brain Embolism Review Article

864

Cardiogenic shock

865

Cardiogenic shock

866

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

867

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

868

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

869

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

870

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

871

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

872

Cardiogenic shock complicating acute coronary syndromes

873

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

874

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

875

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

876

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

877

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

878

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

879

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

880

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

881

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

882

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

883

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

884

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

885

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

886

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

887

Cardiogenic shock: Basics and clinical considerations

888

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

889

Cardiogenic shock: is there light at the end of the tunnel?

890

Cardiographic conundrum: Adding insult to injury

891

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

892

Cardioinhibitory syncope due to bloodphobia associated asystole

893

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

894

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

895

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

896

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

897

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

898

Cardiological applications of nuclear medicine Review Article

899

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

900

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

901

Cardiologist in the carotids

902

Cardiologist in the dugout

903

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

904

Cardiologist on trial: reflections on credible evidence

905

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

906

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

907

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

908

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

909

Cardiologists in casualty?

910

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

911

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

912

Cardiologists recommend Fragmin

913

Cardiologists versus internists in the care of unstable angin

914

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

915

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

916

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

917

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

918

Cardiology and emergency medicine: United We Stand, divided we fall

919

Cardiology and neurologic family screening in noncompaction

920

Cardiology and the Critical Care Crisis: A Perspective Review Article

921

Cardiology in a Flat World

922

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

923

Cardiology in contemporary China: An update

924

Cardiology in India

925

Cardiology in India: State of the Art or Straight off the Heart?

926

Cardiology in South America

927

Cardiology Integration: Challenge and Opportunity

928

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

929

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

930

Cardiology rounds

931

Cardiology screening on the net

932

Cardiology Workforce Crisis: Shortage or Surplus?

933

Cardiology Workforce Revisited

934

Cardiology workforce: there’s already a shortage, and it’s getting worse!

935

Cardiology, for what itʹs worth

936

Cardiology: “Itʹs small world after all”

937

Cardiology: a call for papers

938

Cardiology: American Journal of Medicine theme issue

939

Cardiology: call for papers

940

Cardiology: the past, the present, and the future

941

Cardiology: where to go from here?

942

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

943

Cardiomegaly in a young infant

944

Cardiometabolic Abnormalities in Current National Football League Players

945

Cardiometabolic Consequences of Gestational Dysglycemia

946

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

947

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

948

Cardio-metabolic risk factors in Iranian children: where we are and the others?

949

Cardiometabolic risk factors in polycystic ovary syndrome

950

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

951

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

952

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

953

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

954

Cardiomyocyte death and renewal in the normal and diseased heart

955

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

956

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

957

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

958

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

959

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

960

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

961

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

962

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

963

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

964

Cardiomyocyte Transplantation Improves Heart Function

965

Cardiomyocyte-restricted deletion of connexin43 during mouse development

966

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

967

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

968

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

969

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

970

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

971

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

972

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

973

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

974

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

975

Cardiomyopathic lentiginosis: an echo-Doppler report

976

Cardiomyopathies: from genetics to the prospect of treatment

977

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

978

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

979

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

980

Cardiomyopathy in a Male with Cystinosis

981

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

982

Cardiomyopathy in Danish patients with coeliac disease

983

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

984

Cardiomyopathy in neurological disorders

985

CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.

986

Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis

987

Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy

988

Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports

989

Cardiomyopathy, nephropathy, and death in a 44-year-old man

990

Cardiomyopathy: a role for nitric oxide?

991

Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)

992

Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator

993

Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression

994

Cardiomyoplasty: Is it time to wrap it up?

995

Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ

996

Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease

997

Cardio-Oncology in Iran: Cardio-toxicity Registry

998

Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus

999

Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding

1000

Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

بازگشت